114 related articles for article (PubMed ID: 30879098)
21. Consumption Threshold at Which Virtue Products Become Vice Products: The Case of Beer.
Ruiz-Conde E; Mas-Ruiz F; Parreño-Selva J
Foods; 2021 Jul; 10(8):. PubMed ID: 34441466
[TBL] [Abstract][Full Text] [Related]
22. Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.
Buyco DG; Dempsey JL; Scorletti E; Jeon S; Lin C; Harkin J; Bayen S; Furth EE; Martin J; Delima M; Hooks R; Sostre-Colón J; Gharib SA; Titchenell PM; Carr RM
PLoS One; 2023; 18(5):e0281954. PubMed ID: 37134024
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional and Epigenetic Regulation of Monocyte and Macrophage Dysfunction by Chronic Alcohol Consumption.
Malherbe DC; Messaoudi I
Front Immunol; 2022; 13():911951. PubMed ID: 35844518
[TBL] [Abstract][Full Text] [Related]
24. Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.
Kang K; Sun Y; Pan D; Sang LX; Sun MJ; Li YL; Chang B
Exp Ther Med; 2021 May; 21(5):418. PubMed ID: 33777186
[TBL] [Abstract][Full Text] [Related]
25. Experimental models of metabolic and alcoholic fatty liver disease.
Buyco DG; Martin J; Jeon S; Hooks R; Lin C; Carr R
World J Gastroenterol; 2021 Jan; 27(1):1-18. PubMed ID: 33505147
[TBL] [Abstract][Full Text] [Related]
26. Oxidative Stress Parameters in the Liver of Growing Male Rats Receiving Various Alcoholic Beverages.
Kołota A; Głąbska D; Oczkowski M; Gromadzka-Ostrowska J
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31935882
[TBL] [Abstract][Full Text] [Related]
27. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling.
Shabalala SC; Dludla PV; Mabasa L; Kappo AP; Basson AK; Pheiffer C; Johnson R
Biomed Pharmacother; 2020 Nov; 131():110785. PubMed ID: 33152943
[TBL] [Abstract][Full Text] [Related]
28. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
Finelli C; Tarantino G
World J Gastroenterol; 2013 Feb; 19(6):802-12. PubMed ID: 23430039
[TBL] [Abstract][Full Text] [Related]
29. Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice.
Jung F; Lippmann T; Brandt A; Jin CJ; Engstler AJ; Baumann A
Eur J Nutr; 2020 Mar; 59(2):787-799. PubMed ID: 30879098
[TBL] [Abstract][Full Text] [Related]
30. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
[TBL] [Abstract][Full Text] [Related]
31. GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
Baumann A; Burger K; Brandt A; Staltner R; Jung F; Rajcic D; Lorenzo Pisarello MJ; Bergheim I
Metabolism; 2022 Aug; 133():155233. PubMed ID: 35654114
[TBL] [Abstract][Full Text] [Related]
32. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
33. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.
Kanuri G; Landmann M; Priebs J; Spruss A; Löscher M; Ziegenhardt D; Röhl C; Degen C; Bergheim I
Eur J Nutr; 2016 Apr; 55(3):1153-64. PubMed ID: 26003186
[TBL] [Abstract][Full Text] [Related]
34. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
35. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Risk Factor Collaborators
Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
[TBL] [Abstract][Full Text] [Related]
36. Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease.
Patel PJ; Smith D; Connor JP; Horsfall LU; Hayward KL; Hossain F; Williams S; Johnson T; Stuart KA; Brown NN; Saad N; Clouston AD; Irvine KM; Russell AW; Valery PC; Powell EE
Can J Gastroenterol Hepatol; 2017; 2017():7927685. PubMed ID: 29226116
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
